Abstract: A newly recognized primary cause of the obesity epidemic is the developmental programming effects of infants born to mothers with obesity or gestational diabetes, intrauterine growth-restricted newborns, and offspring exposed to environmental toxins including bisphenol A. The mechanisms which result in offspring obesity include the programming of the hypothalamic appetite pathway and adipogenic signals regulating lipogenesis. Processes include nutrient sensors, epigenetic modifications, and alterations in stem cell precursors of both appetite/satiety neurons and adipocytes which are modulated to potentiate offspring obesity. Future strategies for the prevention and therapy of obesity must address programming effects of the early life environment.
Obesity represents a public health crisis, contributing importantly to morbidity and mortality throughout the United States and the developed world. Obesity is central to the development of metabolic syndrome, which includes a constellation of abnormalities comprised of insulin resistance, elevated triglycerides, hypertension, and atherosclerosis. Among US adults, 66% are overweight (BMI 25 to <30 kg/m 2 ) and 33% are obese (BMIZ 30 kg/m 2 ), whereas 20% of children are obese, and thus at increased risk of adult obesity. Among childbearing women, there has been a continued increase in prevalence of obesity, with a 25% to 36% increase in maternal BMI over the last decade. In conjunction, we have www.clinicalobgyn.com | 529
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witnessed a spectrum of pregnancy complications and a 25% increase in the incidence of high birthweight babies, which itself represents a risk factor for childhood obesity. Although much attention has been focused on the role of environmental factors, including the availability of calorie-dense foods and lifestyles involving less physical work, this review will present evidence that the predisposition to obesity may be programmed, or predetermined in utero. The underlying mechanisms that result in obesity include a dysregulation of appetite/satiety and adipogenesis/lipid metabolism.
Programmed Obesity

HUMANS
Human epidemiological studies have confirmed that both low and high birthweights result in an increased risk for childhood and adult obesity (reviewed in Gluckman et al 1 ) . Intrauterine growthrestricted (IUGR) or low birthweight infants, particularly those with rapid catch-up growth in the first several years of life, have higher risk of adult obesity and metabolic syndrome.
1,2 Although IUGR infants develop in a state of relative ''undernutrition,'' fetal ''overnutrition'' also has consequence for offspring health. Specifically, maternal obesity during pregnancy, or increased weight gain in pregnancy, is associated with higher birthweight newborns 3 and an increased risk of obesity and diabetes risk in later life.
There may well be an optimal newborn weight (potentially specific to an individual mother) at which the programming of obesity potential is minimized. However, within ranges of lower to higher birthweights, studies indicate a gradation of increased propensity to program offspring obesity. Thus, alterations from ''optimal'' in utero growth, be it from limited or excess nutrition, increase the relative risk of adult metabolic syndrome.
ANIMAL MODELS
Animal models of IUGR, using a variety of methods, such as maternal nutrient restriction, placental uterine ligation, or glucocorticoid exposure, have demonstrated that IUGR offspring are at an increased risk of adult adiposity, 4 particularly among those who evident rapid catch-up growth. 5 More recent animal models of maternal overnutrition, including maternal obesity and Western, high-fat (HF) diets similarly replicate the human experience in that offspring are predisposed to adult obesity. 5 
Mechanisms Of Nutrition-Induced Programmed Obesity
As noted above, increased appetite and enhanced adipogenesis represent critical pathways promoting obesity.
Appetite
Studies have demonstrated that programmed appetite dysregulation contributes to obese phenotype in IUGR and HF offspring. 6 We will briefly describe the development of appetite/satiety neurons to demonstrate potential mechanisms by which a programmed enhanced appetite and/or reduced satiety can develop.
Appetite is primarily controlled by a complex circuit of hypothalamic nuclei involved in synthesis of appetite/satiety signals, action areas where messengers act at regulatory sites. The predominant appetite regulatory site, the hypothalamic arcuate nucleus (ARC) receives input from peripheral (brain, pancreas, and adipocytes) and central sources. The ARC contains at least 2 populations of neurons with opposing The hypothalamic regulation of appetite and satiety function develops in utero in precocial species to prepare for newborn life, although there is continued neural development and maturation during the neonatal period. 7 Thus, nutritional effects during the fetal and/or newborn period may permanently ''program'' ARC structure and function and influence appetite and development of obesity. During this period of development, hypothalamic neural stem cells (NSC) proliferate and ultimately differentiate into neurons, astrocytes, or oligodendrocytes which migrate and populate hypothalamic nuclei. Once NSCs differentiate to neurons, those cells destined for the ARC appetite center further differentiate to express orexigenic or anorexigenic peptides. NSC differentiation to neurons or glial cells and the ultimate differentiation to appetite or satiety neurons is regulated by a complex spatial/ temporal interplay of pathways, which may be significantly altered by the nutrient environment or select toxins.
In our laboratory studies, we have confirmed that maternal undernutrition results in IUGR pups, which when nursed by control dams demonstrate significantly increased food intake with rapid catch-up growth and adult obesity. 5, 8 The obese phenotype is a result of dysfunction at several levels of the appetite/satiety pathway, as evidenced by reduced satiety responses to leptin, 9 impaired ARC signaling responses to leptin, 9 and increased responses to appetite stimulatory factors (ie, ghrelin). 6 Our studies and others have confirmed that in response to maternal undernutrition, offspring may express an increased ratio of appetite/satiety gene expression. [10] [11] [12] [13] We have further explored the mechanisms which contribute to the programmed upregulation of appetite, using a model of hypothalamic NSCs which form the appetite neurons. We have demonstrated that NSCs from IUGR fetuses exhibit reduced migration in vivo, and reduced proliferation and neuronal differentiation in vitro.
14 Importantly, even in culture media outside the fetal environment, IUGR NSCs are programmed to preferentially differentiate to appetite as compared with satiety neurons (Desai M, Ross MG, unpublished data, 2013). Maternal obesity/HF diet also results in pups which demonstrate increased food intake and adult obesity. 15 Thus, both maternal undermalnutrition or overmalnutrition may program offspring hyperphagia and metabolic syndrome.
Adipose Tissue
In addition to programmed appetite/satiety, evidence indicates that mechanisms regulating adipose tissue development and function (lipogenesis) may be a key factor in the development of programmed obesity. Adipogenesis is the process of cell differentiation by which preadipocytes become adipocytes and requires highly organized and precisely controlled expression of a cascade of transcription factors which, similar to neural development, may be influenced by the nutrient environment.
ADIPOGENESIS AND LIPOGENESIS
The cellular development associated with adipose tissue growth involves both cellular hyperplasia (increase in cell number) and hypertrophy (increase in cell size). Hyperplasia (adipogenesis) involves the proliferation and differentiation of preadipocytes, whereas hypertrophy is the result of excess triglyceride accumulation in existing adipocytes due to a positive energy balance. Mechanistic studies on enhanced adipogenesis or 16 as evident by an increased expression of enzymes promoting adipocyte lipid synthesis and storage. As these changes are evident early in life before the onset of obesity, it suggests a programmed pathway of increased adipocyte differentiation and lipogenesis which likely promotes the development of obesity and metabolic abnormalities in IUGR offspring. 5, 16 We have further explored whether the increased adipogenic potential of IUGR adipocytes is due to an intrinsic cellular change by utilizing a primary adipocyte cell culture. IUGR adipocytes in culture retain the phenotype of enhanced adipogenesis, evidenced by growth in culture and also enzyme/signaling expression. 17 Thus, the adipocyte itself exhibits ''programmed'' adipogenesis/lipogenesis, independent of the IUGR hormonal milieu.
Our initial mechanistic studies of offspring of obese HF mothers similarly demonstrate an enhanced adipogenesis, akin to IUGR newborns. Thus both undernutrition and overnutrition programs increased adipogenesis. Although the downstream adipogenic signaling factors are similar in both IUGR and HF offspring, there are marked differences in the nutrient/energy sensors responses, dependent upon the primary nutrient stress. 18 
Environmental Obesogens
Increasing human exposure to a wide range of industrial/agricultural chemicals has been well recognized. The CDC reported significant human exposure to endocrine-disrupter chemicals (EDCs), including those acting through estrogen receptors (eEDC). Both adults and children are routinely exposed to bisphenol A (BPA), as there is measurable BPA in breast milk, maternal and fetal serum, amniotic fluid, and placental tissues. 19 Importantly, the level of BPA is higher in infants and children than in adults.
There is accumulating data that endogenous estrogens and eEDCs are involved in both body weight and energy regulation. Estrogen treatment of hamsters decreases body weight and fat, and deficiency of estrogens in animals or women results in fat accrual. 20 In contrast to adult effects, developmental eEDC exposure may impact offspring body weight through changes in adipocyte or NSC growth and differentiation and long-term epigenetic modifications. Offspring of rats exposed perinatally to low-dose BPA exhibit an increased body weight, whereas mice exposed to low BPA from mid to late gestation have increased body mass at birth and weaning. Notably, low rather than high dose of maternal BPA has been reported to be effective in promoting offspring weight gain. Importantly, these adverse effects seen in animals at ''low dose'' are well within the range of human exposure to BPA.
In humans, epidemiological studies support the association of developmental EDC exposure and obesity in later life. Prenatal and early life polychlorinated bisphenyl exposure is associated with increased male and female weight at puberty, in utero exposure to hexachlorobenzene is linked to overweight children at the age of 6, and organochlorine pesticides are positively associated with BMI.
MECHANISMS OF BPA-INDUCED PROGRAMMED OBESITY
Similar to mechanisms by which undernutrition and overnutrition program appetite/ satiety and adipogenesis, BPA exposure may result in adult obesity. Proadipogenic effects of environmental obesogens have been well documented, with recent studies demonstrating effects on adipocyte generation, differentiation, and lipogenic function, with potential epigenetic effects traversing generations. In addition to adipogenic effects, low-dose maternal BPA exposure has been shown to accelerate neurogenesis and neuronal migration in mice, and result in aberrant neuronal network formation. Prenatal/neonatal BPA exposure induces dysfunction of the hippocampal cholinergic system. As a consequence of accelerated neurogenesis, maternal BPA reduces the fetal (e14.5) neural stem/progenitor cell population.
In our preliminary studies, pregnant dams were administered oral BPA from gestational day 10 to term showed increased body weights and food intake. Offspring of BPA dams were heavier at 1 day and 3 weeks of age, indicating earlyonset obesity. We further explored the effects of BPA on preadipocyte and NSC proliferation. Preadipocytes and hypothalamic NSCs treated with BPA for 5 days demonstrated increased proliferation. These findings suggest that environmental toxin, particularly endocrine disrupter compounds such as BPA, may have marked effects on fetal neurogenesis and adipogenesis, potentially contributing to the current obesity epidemic.
Epigenetics and Programming
The essential concept of ''gestational programming'' signifies that the nutritional, hormonal, and metabolic environment provided by the mother permanently alters organ structure, cellular responses, and
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Alteration of epigenome, cell proliferation, cell differentiation, gene expression, structure, function FIGURE 1. In utero programming of obesity. Maternal nutritional and environmental chemical exposure may alter fetal epigenome, stem cell proliferation/differentiation, and/or organ structure that ultimately impact appetite and adipose tissue function of her offspring.
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gene expression that ultimately impact metabolism and physiology of her offspring (Fig. 1) Finally, microRNAs are emerging as a potential third epigenetic mediator. Although these noncoding RNAs are usually associated with regulation of gene expression at the translational level, recent work suggests they may be involved in DNA methylation as well, thereby further regulating transcription of their targets.
Through these series of epigenetic mediators, in utero nutrition, environmental exposures, and likely other factors (eg, stress) may permanently alter offspring gene expression, and the structure and function of cells and organs (Fig. 2) .
Therapies, Applications, and Conclusions
The obesity epidemic represents one of the major public health challenges in the 21st century. Devising effective policy and practice to combat childhood obesity is a high priority for many governments and health professionals. There is irrevocable evidence that departures from optimal growth in utero, whether from limited or excess nutrition, and new evidence that exposure to select environmental toxins, increase the relative risk of adult obesity. Alterations in epigenomics may be a key mechanism by which environmental exposures can influence gene expression, and therefore, phenotype. Future strategies for the prevention and therapy of obesity will ideally address programming effects of the early life environment. Most importantly, it is critical that we recognize that obese individuals truly may have an enhanced appetite and a predisposition to lipid storage and adipogenesis.
